NUCLEAR MEDICINE COMMUNICATIONS, cilt.34, sa.6, ss.571-576, 2013 (SCI-Expanded)
Objectives The aim of the study was to evaluate the role of F-18-fluorodeoxyglucose (F-18-FDG) PET/computed tomography (CT) in the early postoperative staging of breast cancer and to document F-18-FDG PET/CT-based stage alterations and any subsequent impact on management.